Interview with Professor Krzysztof Selmai, director of the Center for Neurology in Lodz, head of the Department of Neurology at the University of Warmia and Mazury in Olsztyn
The Multiple Sclerosis 2023 Neurology Conference is behind us, and a great deal of attention has been given to the prospect of living with the disease. How do you view recent developments in MS diagnosis and treatment?
At the end of last year, a big change took place in patients' access to high-cost treatment. We have been waiting for this change for a very long time. The fact that we now have several high-efficacy drugs that we can use without the initial barrier of treatment with basic drugs is a very good and important change. We hope that this will definitely improve the results of t...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in
